Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis

Annals of the New York Academy of Sciences

Volumn 1173, Issue SUPPL. 1, 2009, Pages

  Lumachi, Franco ^a   Ermani, Mario ^b   Camozzi, Valentina ^c   Tombolan, Valeria ^a   Luisetto, Giovanni ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b Biostatistics Unit Policlinico di Monza   (Italy)

^c Division of Endocrinology   (Italy)

Author keywords

alkaline phosphatase; bone mineral density; menopause; osteocalcin; osteodensitometry; osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CREATININE; OSTEOCALCIN; PARATHYROID HORMONE; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE TURNOVER; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; HUMAN; OSSIFICATION; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; POSTMENOPAUSE; BLOOD; BONE DEVELOPMENT; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT SELECTION; PHOTON ABSORPTIOMETRY; PHYSIOLOGY;

ABSORPTIOMETRY, PHOTON; AGED; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE DENSITY; BONE DEVELOPMENT; CALCIUM; CREATININE; FEMALE; HUMANS; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS; PARATHYROID HORMONE; PATIENT SELECTION; POSTMENOPAUSE;

EID: 70350452035     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04953.x     Document Type: Article

References (17)

1. Shoback, D. et al. 2001. Mineral metabolism & metabolic bone disease. In Basic and Clinical Endocrinology. F.S. Greenspan & D.G. Gardner, Eds.: 273-333. LangeMedical Books/McGraw-Hill. NewYork, NY.
2. Lumachi, F., M. Ermani, S.M.M. Basso, et al. 2003. Short- and long-term changes in bone mineral density of the lumbar spine after parathyroidectomy in patients with primary hyperparathyroidism. Calcif. Tissue Int. 73: 44-48.
3. Delmas, P.D., R. Eastell, P. Gardner, et al. Committee of Scientific Advisors of the International Osteoporosis Foundation. 2000. The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisor of the International Osteoporosis Foundation. Osteoporos. Int. 11: S2-S17.
4. Camozzi, V., F. Lumachi, M. Piccolo, et al. 2003. Phalangeal quantitative ultrasound technology and dual energy X-ray densitometry in patients with primary hyperparathyroidism: influence of sex and menopausal status. Osteoporos. Int. 14: 602-608.
5. Lumachi, F., M. Ermani, F. Marino, et al. 2006. PCNA-LI, Ki-67 immunostaining, p53 activity and histopathological variables in predicting the clinical outcome in patients with parathyroid carcinoma. Anticancer Res. 25: 1305-1308.
6. Lumachi, F., V. Camozzi, M. Ermani, et al. 2007. Bone mineral density improvement after successful parathyroidectomy in pre- and postmenopausal women with primary hyperparathyroidism. Ann. N. Y. Acad. Sci. 1117: 357-361.
7. Bainbridge, K.E., M.F. Sowers,M. Crutchfield, et al. 2000. Natural history of bone loss over 6 years among premenopausal and early postmenopausal women. Am. J. Epidemiol. 156: 410-417.
8. Sowers, M., M.L. Jannausch, W. Liang, et al. 2004. Estrogen receptor genotypes and their association with the 10-year changes in bonemineral density and osteocalcin concentrations. J. Clin. Endocrinol. Metab. 89: 733-739.
9. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. 2001. Osteoporosis prevention, diagnosis, and therapy. JAMA 285: 785-795.
10. Grundberg, C.M., A.C. Looker, S.D. Nieman, et al. 2002. Patterns of osteocalcin and bone specific alkaline phosphatase by age, gender, and race or ethnicity. Bone 31: 703-708.
11. Owroll, E.S. & L.J. Deftos. 1990. Serum osteocalcin (BGP) levels in normalmen: a longitudinal evaluationreveals an age-associated increase. J. Bone Miner. Res. 5: 259-262.
12. Liu, G. & M. Peacock. 1998. Age-related changes in serum undecarbossilated osteocalcin and its relationship with bone density, bone quality, and hip fracture. Calcif. Tissue Int. 62: 286-289.
13. Minisola, S., R. Rosso, E. Romagnoli, et al. 1997. Serum osteocalcin and bone mineral density at various skeletal sites: a study performed with three different assays. J. Lab. Clin. Med. 129: 422-429.
14. Knapen, M.H.J., A.C. Nieuwenhuijzen Kruseman, R.S.M. Wouters, et al. 1998. Correlation of serumosteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calcif. Tissue Int. 63: 375-379.
15. Cheng, S., H. Souminten, K. Väänänen, et al. 2002. Serum osteocalcin in relation to calcaneal bone mineral density in elderly men and women: a 5-year follow-up. J. Bone Min. Metab. 20: 49-56.
16. Lukacs, J.L., S. Booth, M. Kleerekoper, et al. 2006. Differential associations for menopause and age in measures of vitamin K, osteocalcin, and bone density: a cross-selectional exploratory study in healthy volunteers. Menopause 13: 799-808.
17. Reginster, J.-Y., J. Collette, A. Neuprez, et al. 2008. Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy. Bone 42: 832-836.